Suscribirse

Pneumonia severity indices predict prognosis in coronavirus disease-2019 - 11/06/21

Doi : 10.1016/j.resmer.2021.100826 
E.S. Ucan a, A. Ozgen Alpaydin a, , S.S. Ozuygur a, S. Ercan a, B. Unal b, A.A. Sayiner c, B. Ergan a, N. Gokmen d, Y. Savran e, O. Kilinc a, V. Avkan Oguz f

DEU COVID Study Group1

  DEU COVID Study Group (in alphabetical order): Firat Bayraktar, M.D., Caner Cavdar, M.D., Sema Alp Cavus, M.D., Ziya Kuruuzum, M.D., Can Sevinc, M.D., Gokcen Omeroglu Simsek, M.D., Isıl Somali, M.D, Mujde Soyturk, M.D., Kemal Can Tertemiz, M.D., Serkan Yildiz, M.D.

a Department of Pulmonary Diseases, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey 
b Department of Public Health, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey 
c Department of Medical Microbiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey 
d Department of Anesthesiology and Reanimation, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey 
e Department of Internal Medicine, Medicana International Izmir Hospital, Izmir, Turkey 
f Department of Infectious Diseases and Clinical Microbiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey 

Corresponding Author: Department of Pulmonary Diseases, Dokuz Eylul University Faculty of Medicine, Inciraltı 35340 Izmir, Turkey.Department of Pulmonary Diseases, Dokuz Eylul University Faculty of MedicineInciraltı Izmir35340Turkey

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

Early recognition of the severe illness is critical in coronavirus disease-19 (COVID-19) to provide best care and optimize the use of limited resources.

Objectives

We aimed to determine the predictive properties of common community-acquired pneumonia (CAP) severity scores and COVID-19 specific indices.

Methods

In this retrospective cohort, COVID-19 patients hospitalized in a teaching hospital between 18 March-20 May 2020 were included. Demographic, clinical, and laboratory characteristics related to severity and mortality were measured and CURB-65, PSI, A-DROP, CALL, and COVID-GRAM scores were calculated as defined previously in the literature. Progression to severe disease and in-hospital/overall mortality during the follow-up of the patients were determined from electronic records. Kaplan-Meier, log-rank test, and Cox proportional hazard regression model was used. The discrimination capability of pneumonia severity indices was evaluated by receiver-operating-characteristic (ROC) analysis.

Results

Two hundred ninety-eight patients were included in the study. Sixty-two patients (20.8%) presented with severe COVID-19 while thirty-one (10.4%) developed severe COVID-19 at any time from the admission. In-hospital mortality was 39 (13.1%) while the overall mortality was 44 (14.8%). The mortality in low-risk groups that were identified to manage outside the hospital was 0 in CALL Class A, 1.67% in PSI low risk, and 2.68% in CURB-65 low-risk. However, the AUCs for the mortality prediction in COVID-19 were 0.875, 0.873, 0.859, 0.855, and 0.828 for A-DROP, PSI, CURB-65, COVID-GRAM, and CALL scores respectively. The AUCs for the prediction of progression to severe disease was 0.739, 0.711, 0,697, 0.673, and 0.668 for CURB-65, CALL, PSI, COVID-GRAM, A-DROP respectively. The hazard ratios (HR) for the tested pneumonia severity indices demonstrated that A-DROP and CURB-65 scores had the strongest association with mortality, and PSI, and COVID-GRAM scores predicted mortality independent from age and comorbidity.

Conclusion

Community-acquired pneumonia (CAP) scores can predict in COVID-19. The indices proposed specifically to COVID-19 work less than nonspecific scoring systems surprisingly. The CALL score may be used to decide outpatient management in COVID-19.

El texto completo de este artículo está disponible en PDF.

Keywords : CAP, COVID-19, CALL score, COVID-GRAM score, Pneumonia severity indices, A-DROP, CURB-65, PSI, PSI/PORT


Esquema


© 2021  SPLF and Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 79

Artículo 100826- mai 2021 Regresar al número
Artículo precedente Artículo precedente
  • Spirometric restrictive ventilatory pattern and type 2 diabetes mellitus in a tertiary hospital in Cameroon: A comparative study
  • S.E. Ndouga, V. Poka-Mayap, A. Dodo Balkissou, A. Djenabou, A. Kuaban, A. Haman, A. Ofimboudem-Nguetsa, E. Sobngwi, E.W. Pefura-Yone
| Artículo siguiente Artículo siguiente
  • Sampling strategy for bacteriological diagnosis of intrathoracic tuberculosis
  • T. Maitre, V. Ok, F. Morel, I. Bonnet, W. Sougakoff, J. Robert, V. Trosini, E. Caumes, A. Aubry, N. Veziris

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.